Adhera Therapeutics, Inc. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, Salberg & Company, P.A., gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.006 USD | -32.58% | -10.45% | -80.00% |
1st Jan change | Capi. | |
---|---|---|
-80.00% | 69.76K | |
-1.75% | 104B | |
+6.78% | 97.47B | |
+5.71% | 22.25B | |
-12.89% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.25% | 16.36B | |
+6.51% | 14.39B | |
+35.21% | 12.37B |
- Stock Market
- Equities
- ATRX Stock
- News Adhera Therapeutics, Inc.
- Adhera Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt